What does it take to build a supplement brand around transparency, science, and trust? 💊🔬

Kat Schneider, Founder and CEO of Ritual, shares how her search for a prenatal vitamin she could trust inspired her to rethink what the supplement industry could look like. What began during her pregnancy grew into a company focused on traceable ingredients, third-party certifications, clinical research, and understanding not only what goes into a supplement, but how it works in the body.

Kat explains why Ritual built a traceable supply chain that allows consumers to see where ingredients come from and why they are included. 🌎 She also breaks down what consumers should look for when choosing supplements, including certifications from organizations like Clean Label Project, NSF, and USP, and why the phrase “clinically studied” does not always tell the whole story.

The conversation also explores the technology behind supplement delivery, including delayed-release capsules, Ritual’s beadlet-and-oil design, and systems designed to deliver certain ingredients where they can be better utilized by the body. 🧬 Kat shares how Ritual approaches product development through ingredient quality, sourcing, safety, delivery, and clinical research.

Looking ahead, Kat discusses the future of personalized health and the need for more research focused on women throughout different stages of life, including fertility, pregnancy, postpartum, perimenopause, and menopause. She also explains why emerging data from wearables and AI-driven recommendations will only be as valuable as the science behind them. 💡

Listen to the full conversation to hear how Ritual is combining science, transparency, and product innovation to rethink the future of supplements and women’s health. 🎧

Collaborate with us!

Support the show

For more information about the innovations that are shaping tomorrow's world, head to https://tomorrowsworldtoday.com/

To keep up-to-date with the latest in innovation, technology, sustainability, and more connect with us on social:
YouTube
Instagram
Facebook
Twitter
LinkedIn

You know the drill - there are certain cancer screenings that you can identify almost immediately: mammograms, colon screenings, Pap tests, and lung cancer screenings for those at high risk of developing the disease. Yet, what about the other various forms of cancer that do not come with routine screening protocols? David Harding, the Senior Vice President of Pipeline Product Management at Abbott, shares how multicancer early detection testing is changing the game with a simple blood draw.

Cancerguard®, a prescription-based test, analyzes for up to 50 cancer types and subtypes. The test analyzes for the presence of methylated DNA fragments from tumors and the proteins released by those tumors. These biomarkers return test results and tell the patient whether cancer signals were detected. This further underlines the importance of undergoing routine cancer screenings regardless of the test results.

Beyond the science behind the Cancerguard® test, there’s the more emotional component to cancer testing: the fear of the testing, the anxiety of potential cancerous diagnoses, and the role of care navigators in assisting cancer patients in taking the next steps in their treatment journey. Additionally, he discusses the challenges of taking a molecular diagnostic test to market, how the test is currently available, and has not yet received FDA approval, and the long-term efforts to fund research and development of the test.

_______________________________________

Early detection can change everything in cancer care. 🧬

David Harding, Senior Vice President of Pipeline Product Management at Abbott, shares how new testing approaches are expanding what’s possible in screening.

Collaborate with us!

Support the show

For more information about the innovations that are shaping tomorrow's world, head to https://tomorrowsworldtoday.com/

To keep up-to-date with the latest in innovation, technology, sustainability, and more connect with us on social:
YouTube
Instagram
Facebook
Twitter
LinkedIn

Our car spends most of its life parked. Why, then, do we treat it like it only matters when it’s moving? On this episode, we sit down with Norman Lu, Senior Program Manager at Toyota North America, to talk about how to turn EV charging from a source of anxiety into a source of value for car owners. 🚗

Norman joins us to discuss what has changed in battery-electric vehicles over time, why the range is sufficient for most drivers today, and the biggest barriers to EV adoption. He explains how electric vehicles can act as energy storage systems for the grid and how the battery in a single electric vehicle can provide enough power to keep a home running during an outage. Additionally, he shares his thoughts on vehicle-to-grid programs and the problems with the electrical grid today. ⚡️

Norman also shares his thoughts on wireless EV charging, vehicle-to-grid programs, solar on vehicles, and the importance of connectivity for the cars of the future. He also shares with us the challenges of innovation within a giant company like Toyota, and his thoughts on the company’s different approaches to electric vehicles. 📶

_________________________________________________

What does the future of driving look like? Wireless charging, smarter energy use, and more personalized vehicles. 🚗📶 Norman Lu, Senior Program Manager at Toyota North America, gives a look into what’s coming next.

Collaborate with us!

Support the show

For more information about the innovations that are shaping tomorrow's world, head to https://tomorrowsworldtoday.com/

To keep up-to-date with the latest in innovation, technology, sustainability, and more connect with us on social:
YouTube
Instagram
Facebook
Twitter
LinkedIn